The devastation caused by the COVID-19 pandemic has prompted scientists to think out-of-the-box to pursue research in areas otherwise not typically investigated. One of such areas involves the global hunt for people with genetic resistance to SARS-CoV-2 infection, with hopes of finding the genetic determinant for protection that could lead to the discovery of novel therapeutic and prophylactic agents.
Although a daunting task to find someone with this genetic determinant, locating even a single person would lead to a major breakthrough. A similar strategy has been previously tried with HIV that led to the identification of a rare mutation that disables the CCR5 receptor on white blood cells, preventing HIV from entering them and ultimately leading to the discovery of a class of HIV-blocking drugs. Two people were also apparently cleared of HIV after receiving bone-marrow transplants from donors with two copies of the resistant genes.
Since SARS-CoV-2 uses ACE2 receptors to enter cells, there is a very high likelihood that any rare mutation would probably reduce expression of the ACE2 gene, thus diminishing the risk of COVID infection.
For further information, click here to read more.
Comments